SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER IN RHEUMATOID ARTHRITIS PATIENTS Dore, R. K., Antonova, J., Huan, H., Gorritz, M., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 700

View details for DOI 10.1136/annrheumdis-2019-eular.1848

View details for Web of Science ID 000472207102120